MarketView

MarketView

RXA MarketView enables pharmaceutical companies to analyse the current prescribing of a new or potential product and help to develop a market entry strategy.

The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.

With the RXA MarketView tool you can:

  • Analyse up to 5 years of NHS prescribing and other sales data
  • See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
  • See data for England, Wales, Scotland and Northern Ireland
  • Select a range of reporting dimensions and filters
    • SHA
    • Area/CCG
    • GP Practice
    • Product
    • Brand vs. Generic
  • View extensive highly visual tables, charts and maps in the purpose-built dashboard
  • Access easy to interpret analytics
  • Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
We make analytics simple
Request your demonstration today

“I am regularly told by my sales team that Inspiremed’s software is one of the best tools in sales, measurement and planning that they’ve ever used.”

National Sales Manager, Leading UK Pharmaceutical Company

“Need to analyse the community market? This tool can do that.”

Senior Manager, Global Healthcare Company, 2016

“Export to Excel is straightforward, which facilitates easy manipulation if required, for example, for territory planning.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Fantastic customer service, any requests from us to fine tune the functionality or appearance of the product is done in most cases on the same day as the request.”

National Sales Manager, UK Pharmaceutical Company

“Budget impact calculation makes for a much more informed discussion with customers where cost savings are a key driver.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Key benefits? Simple graphics that are easy to use in presentations. Easy to download. And the level of available detail – down to GP practice.”

Senior Manager, Global Healthcare Company, 2016

Sign up for added insights